Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Phase I Study of TQ-B3456 on Tolerance and Pharmacokinetics
- Status
- TERMINATED
- Phase
- PHASE1
Genomic Investigation of Unusual Responders
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Anlotinib in Combination With Docetaxel Versus Docetaxel Alone in Participants With Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Anlotinib Combined With Docetaxel Versus Docetaxel for Previous Treated Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Significance of Circulating Tumor Cell in Non Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience
- Status
- COMPLETED
- Phase
- NA
NEUWAVE Flexible Probe Study #2
- Status
- WITHDRAWN
- Phase
- NA
Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Explore Treatment Regimens and Clinical Outcomes of the NSCLC Patients With Different Dirver Genes
- Status
- UNKNOWN
- Phase
- N/A
A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals
- Status
- UNKNOWN
- Phase
- N/A
Fasting-mimicking Diet With Chemo-immunotherapy in Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- NA
Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions and Differentiating Multiple Primary Lung Cancer From Intrapulmonary Metastases of Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC
- Status
- TERMINATED
- Phase
- PHASE1
Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients
- Status
- UNKNOWN
- Phase
- N/A
Biomarkers of Response to Pembrolizumab Combined With Chemotherapy in Non-Small Cell Lung Cancer (KEYNOTE-782, MK-3475-782)
- Status
- COMPLETED
- Phase
- PHASE2